• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Dec 15;13:1076724.
doi: 10.3389/fimmu.2022.1076724. eCollection 2022.
Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection


Logan S Dean[SUP] 1 2 [/SUP], Gehan Devendra[SUP] 3 4 [/SUP], Boonyanudh Jiyarom[SUP] 1 [/SUP], Natalie Subia[SUP] 2 [/SUP], Michelle D Tallquist[SUP] 5 [/SUP], Vivek R Nerurkar[SUP] 2 [/SUP], Sandra P Chang[SUP] 2 [/SUP], Dominic C Chow[SUP] 1 4 [/SUP], Cecilia M Shikuma[SUP] 1 4 [/SUP], Juwon Park[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: Low-density granulocytes (LDGs) are a distinct subset of neutrophils whose increased abundance is associated with the severity of COVID-19. However, the long-term effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on LDG levels and phenotypic alteration remain unexplored.
Methods: Using participants naïve to SARS-CoV-2 (NP), infected with SARS-CoV-2 with no residual symptoms (NRS), and infected with SARS-CoV-2 with chronic pulmonary symptoms (PPASC), we compared LDG levels and their phenotype by measuring the expression of markers for activation, maturation, and neutrophil extracellular trap (NET) formation using flow cytometry.
Results: The number of LDGs was elevated in PPASC compared to NP. Individuals infected with SARS-CoV-2 (NRS and PPASC) demonstrated increased CD10[SUP]+[/SUP] and CD16[SUP]hi[/SUP] subset counts of LDGs compared to NP group. Further characterization of LDGs demonstrated that LDGs from COVID-19 convalescents (PPASC and NRS) displayed increased markers of NET forming ability and aggregation with platelets compared to LDGs from NP, but no differences were observed between PPASC and NRS.
Conclusions: Our data from a small cohort study demonstrates that mature neutrophils with a heightened activation phenotype remain in circulation long after initial SARS-CoV-2 infection. Persistent elevation of markers for neutrophil activation and NET formation on LDGs, as well as an enhanced proclivity for platelet-neutrophil aggregation (PNA) formation in COVID-19 convalescent individuals may be associated with PPASC prognosis and development.

Keywords: SARS-CoV-2; long-COVID; low-density granulocyte; neutrophil extracellular traps; platelet-neutrophil aggregates; platelets; post-acute sequalae of SARS-CoV-2 infection; pulmonary sequelae.
 
Back
Top Bottom